Correlation Between Annovis Bio and Immunome

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Annovis Bio and Immunome at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Annovis Bio and Immunome into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Annovis Bio and Immunome, you can compare the effects of market volatilities on Annovis Bio and Immunome and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Annovis Bio with a short position of Immunome. Check out your portfolio center. Please also check ongoing floating volatility patterns of Annovis Bio and Immunome.

Diversification Opportunities for Annovis Bio and Immunome

0.62
  Correlation Coefficient

Poor diversification

The 3 months correlation between Annovis and Immunome is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Annovis Bio and Immunome in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunome and Annovis Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Annovis Bio are associated (or correlated) with Immunome. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunome has no effect on the direction of Annovis Bio i.e., Annovis Bio and Immunome go up and down completely randomly.

Pair Corralation between Annovis Bio and Immunome

Given the investment horizon of 90 days Annovis Bio is expected to under-perform the Immunome. In addition to that, Annovis Bio is 1.34 times more volatile than Immunome. It trades about -0.26 of its total potential returns per unit of risk. Immunome is currently generating about -0.11 per unit of volatility. If you would invest  1,028  in Immunome on December 30, 2024 and sell it today you would lose (329.00) from holding Immunome or give up 32.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Annovis Bio  vs.  Immunome

 Performance 
       Timeline  
Annovis Bio 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Annovis Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Immunome 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Immunome has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Annovis Bio and Immunome Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Annovis Bio and Immunome

The main advantage of trading using opposite Annovis Bio and Immunome positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Annovis Bio position performs unexpectedly, Immunome can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunome will offset losses from the drop in Immunome's long position.
The idea behind Annovis Bio and Immunome pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals